Get the Stockscreener App
0.3903
0.85%
0.0033
After Hours:
.39
-0.0003
-0.08%
Athira Pharma Inc stock is traded at $0.3903, with a volume of 133.38K.
It is up +0.85% in the last 24 hours and up +4.78% over the past month.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) is a small molecule drug candidate designed to enhance the activity of the neurotrophic hepatocyte growth factor (HGF) system; ATH-1020 a novel, orally available, next-generation small molecule drug candidate designed to positively modulate the neurotrophic HGF system; ATH-1105 is a novel, orally available, next-generation, small molecule drug candidate designed to positively modulate the neurotrophic HGF system.
See More
Previous Close:
$0.387
Open:
$0.381
24h Volume:
133.38K
Relative Volume:
0.33
Market Cap:
$15.39M
Revenue:
-
Net Income/Loss:
$-117.67M
P/E Ratio:
-0.1263
EPS:
-3.09
Net Cash Flow:
$-101.06M
1W Performance:
+0.44%
1M Performance:
+4.78%
6M Performance:
+2.93%
1Y Performance:
-30.54%
1-Day Range:
$0.381
$0.40
1-Week Range:
$0.3711
$0.40
52-Week Range:
$0.2195
$0.8264
Athira Pharma Inc Stock (ATHA) Company Profile
Name
Athira Pharma Inc
Sector
Industry
Phone
(425) 620-8501
Address
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
Compare ATHA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ATHA
Athira Pharma Inc
|
0.3903 | 15.26M | 0 | -117.67M | -101.06M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Athira Pharma Inc Stock (ATHA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-19-24 | Downgrade | Mizuho | Outperform → Neutral |
| Sep-04-24 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-04-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-04-24 | Downgrade | Rodman & Renshaw | Buy → Neutral |
| Aug-19-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-17-22 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Jun-23-22 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-23-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-23-22 | Downgrade | Stifel | Buy → Hold |
| May-10-22 | Initiated | BTIG Research | Buy |
| Apr-21-22 | Initiated | Berenberg | Buy |
| Dec-15-21 | Initiated | Goldman | Neutral |
| Oct-13-20 | Initiated | Goldman | Buy |
| Oct-13-20 | Initiated | JMP Securities | Mkt Outperform |
| Oct-13-20 | Initiated | Jefferies | Buy |
| Oct-13-20 | Initiated | Stifel | Buy |
View All
Athira Pharma Inc Stock (ATHA) Latest News
Can volume confirm reversal in Athira Pharma Inc.Long Setup & Reliable Intraday Trade Alerts - Newser
Using data filters to optimize entry into Athira Pharma Inc.Risk Management & Free Expert Verified Stock Movement Alerts - Newser
Can momentum traders help lift Athira Pharma Inc.Trade Volume Report & Real-Time Buy Signal Alerts - Newser
What moving averages say about Athira Pharma Inc.July 2025 Recap & Expert Approved Momentum Ideas - Newser
Is Athira Pharma Inc. a good ESG investmentJuly 2025 Sector Moves & Weekly Chart Analysis and Guides - خودرو بانک
Using AI based signals to follow Athira Pharma Inc.2025 Market Sentiment & Short-Term High Return Ideas - Newser
Is Athira Pharma Inc. exposed to political riskJuly 2025 Rallies & Free Weekly Watchlist of Top Performers - خودرو بانک
Is Athira Pharma Inc.’s growth already priced inPortfolio Gains Report & Advanced Technical Analysis Signals - خودرو بانک
What Fibonacci levels say about Athira Pharma Inc. reboundMarket Activity Recap & Verified Swing Trading Watchlists - Newser
Is Athira Pharma Inc. stock bottoming outEarnings Overview Summary & Step-by-Step Swing Trade Plans - Newser
Trend Report: Will Athira Pharma Inc. benefit from seasonalityDollar Strength & Weekly Market Pulse Updates - خودرو بانک
Can Athira Pharma Inc. be recession proofMarket Activity Recap & AI Driven Price Predictions - خودرو بانک
Price momentum metrics for Athira Pharma Inc. explainedWeekly Gains Summary & Risk Managed Trade Strategies - Newser
Analyzing net buyer seller activity in Athira Pharma Inc.2025 Support & Resistance & Fast Entry Momentum Alerts - Newser
Is Athira Pharma Inc. stock reversal real or fake2025 Investor Takeaways & Safe Investment Capital Preservation Plans - Newser
Is it too late to sell Athira Pharma Inc.Price Action & Safe Investment Capital Preservation Plans - Newser
Visualizing Athira Pharma Inc. stock with heatmaps2025 Earnings Impact & Real-Time Volume Analysis Alerts - Newser
Does Athira Pharma Inc. show high probability of rebound2025 Institutional Moves & Weekly Setup with High ROI Potential - Newser
Will Athira Pharma Inc. benefit from macro trendsGlobal Markets & Accurate Trade Setup Notifications - Newser
Sentiment analysis tools applied to Athira Pharma Inc.2025 Short Interest & Fast Gaining Stock Reports - Newser
Published on: 2025-09-05 00:35:51 - Newser
Downgrade Watch: Will Athira Pharma Inc. benefit from AI trendsQuarterly Trade Review & Consistent Income Trade Recommendations - خودرو بانک
What MACD signals say about Athira Pharma Inc.Weekly Investment Summary & Low Risk Entry Point Guides - Newser
Is Athira Pharma Inc. forming a breakout patternMarket Trend Report & Weekly Setup with ROI Potential - خودرو بانک
Does Athira Pharma Inc. stock benefit from AI growth2025 Trading Volume Trends & Real-Time Market Sentiment Reports - خودرو بانک
Live market analysis of Athira Pharma Inc.2025 Geopolitical Influence & Accurate Buy Signal Alerts - Newser
Real time pattern detection on Athira Pharma Inc. stock2025 Volatility Report & Verified Entry Point Detection - Newser
What machine learning models say about Athira Pharma Inc.Short Setup & Low Drawdown Momentum Ideas - Newser
Using economic indicators to assess Athira Pharma Inc. potentialJuly 2025 Summary & Free Long-Term Investment Growth Plans - Newser
Loss Report: Will Athira Pharma Inc. benefit from AI trendsProduct Launch & Detailed Earnings Play Alerts - خودرو بانک
What’s next for Athira Pharma Inc. stock priceQuarterly Earnings Summary & Intraday High Probability Setup Alerts - Newser
Smart tools for monitoring Athira Pharma Inc.’s price action2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - Newser
Leading vs lagging indicators on Athira Pharma Inc. performanceWeekly Investment Recap & Technical Pattern Based Signals - Newser
Will Athira Pharma Inc. benefit from AI trendsJuly 2025 Setups & Verified Entry Point Detection - خودرو بانک
Is Athira Pharma Inc. exposed to political risk getLinesFromResByArray error: size == 0 - 시사인 투데이
Athira Pharma (ATHA) Is Paying a $10M Settlement to Investors — Here’s How to Get Your Share - TradingView
Athira Pharma Inc Stock (ATHA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):